NO153298C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-methylenderivater av thienamycin - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-methylenderivater av thienamycin

Info

Publication number
NO153298C
NO153298C NO763958A NO763958A NO153298C NO 153298 C NO153298 C NO 153298C NO 763958 A NO763958 A NO 763958A NO 763958 A NO763958 A NO 763958A NO 153298 C NO153298 C NO 153298C
Authority
NO
Norway
Prior art keywords
therapyutic
methylender
thienamycin
derivatives
preparing
Prior art date
Application number
NO763958A
Other languages
English (en)
Other versions
NO763958L (no
NO153298B (no
Inventor
Burton Grant Christensen
William Joseph Leanza
Kenneth James Wildonger
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NO763958L publication Critical patent/NO763958L/no
Publication of NO153298B publication Critical patent/NO153298B/no
Publication of NO153298C publication Critical patent/NO153298C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/10Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO763958A 1975-11-21 1976-11-19 Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-methylenderivater av thienamycin NO153298C (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US63429675A 1975-11-21 1975-11-21
US67626176A 1976-04-12 1976-04-12
US73365476A 1976-10-18 1976-10-18

Publications (3)

Publication Number Publication Date
NO763958L NO763958L (no) 1977-05-24
NO153298B NO153298B (no) 1985-11-11
NO153298C true NO153298C (no) 1986-02-19

Family

ID=27417545

Family Applications (1)

Application Number Title Priority Date Filing Date
NO763958A NO153298C (no) 1975-11-21 1976-11-19 Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-methylenderivater av thienamycin

Country Status (27)

Country Link
AT (1) AT358168B (no)
AU (1) AU512383B2 (no)
BG (1) BG34037A3 (no)
CA (1) CA1083577A (no)
CH (2) CH632510A5 (no)
DD (1) DD127742A5 (no)
DE (1) DE2652679A1 (no)
DK (1) DK157401C (no)
EG (1) EG12261A (no)
ES (1) ES453501A1 (no)
FI (1) FI62306C (no)
FR (1) FR2332012A1 (no)
GB (1) GB1570990A (no)
GR (1) GR62072B (no)
HK (1) HK29683A (no)
HU (1) HU180865B (no)
IE (1) IE44433B1 (no)
IL (1) IL50911A (no)
KE (1) KE3286A (no)
NL (1) NL189297C (no)
NO (1) NO153298C (no)
NZ (1) NZ182630A (no)
PH (1) PH16714A (no)
PL (1) PL110937B1 (no)
PT (1) PT65865B (no)
SE (1) SE427841B (no)
SG (1) SG10983G (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1593524A (en) * 1976-11-19 1981-07-15 Merck & Co Inc 1-carba-2-penem-3-carboxylic acids
SE436569B (sv) * 1977-05-05 1985-01-07 Merck & Co Inc Analogiforfarande for framstellning av tienamycinderivat
US4232030A (en) * 1977-09-15 1980-11-04 Merck & Co., Inc. Substituted N-methylene derivatives of thienamycin sulfoxide and sulfone
DK153486C (da) * 1978-07-03 1988-11-28 Merck & Co Inc Analogifremgangsmaade til fremstilling af krystallinsk n-formimidoyl-thienamycin-monohydrat
EP0044170A1 (en) * 1980-07-11 1982-01-20 Beecham Group Plc Beta-lactam antibiotics, their preparation and use
WO1992004054A1 (en) * 1990-08-30 1992-03-19 STATE OF OREGON, acting by and through THE OREGON STATE BOARD OF HIGHER EDUCATION, acting for and on behalf of THE OREGON HEALTH SCIENCES UNIVERSITY, PORTLAND, OREGON, and THE UNIVERSITY OF OREGON, EUGENE, OREGON, Johnson Hall, University of Oregon Substituted amidines having high binding to the sigma receptor and the use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1004670A (en) * 1963-04-23 1965-09-15 Beecham Res Lab Penicillins
GB1348985A (en) * 1970-06-16 1974-03-27 Merck & Co Inc Esters of cephalosporin compounds
US3950357A (en) * 1974-11-25 1976-04-13 Merck & Co., Inc. Antibiotics

Also Published As

Publication number Publication date
AU1964776A (en) 1978-05-25
ATA863476A (de) 1980-01-15
PL193809A1 (pl) 1978-01-16
NO763958L (no) 1977-05-24
AT358168B (de) 1980-08-25
ES453501A1 (es) 1978-03-01
FI62306B (fi) 1982-08-31
SG10983G (en) 1983-12-16
DE2652679C2 (no) 1990-03-01
DK523576A (da) 1977-05-22
NL189297C (nl) 1993-03-01
FR2332012A1 (fr) 1977-06-17
PH16714A (en) 1984-01-25
FI62306C (fi) 1982-12-10
CA1083577A (en) 1980-08-12
PL110937B1 (en) 1980-08-30
EG12261A (en) 1978-12-31
NL189297B (nl) 1992-10-01
NL7612939A (nl) 1977-05-24
NZ182630A (en) 1979-07-11
IE44433B1 (en) 1981-12-02
AU512383B2 (en) 1980-10-09
NO153298B (no) 1985-11-11
GB1570990A (en) 1980-07-09
FR2332012B1 (no) 1978-11-17
DE2652679A1 (de) 1977-06-02
PT65865B (en) 1978-10-12
IL50911A0 (en) 1977-01-31
SE427841B (sv) 1983-05-09
IL50911A (en) 1981-01-30
SE7612963L (sv) 1977-05-22
CH632510A5 (en) 1982-10-15
HU180865B (en) 1983-04-29
DK157401B (da) 1990-01-02
PT65865A (en) 1976-12-01
HK29683A (en) 1983-08-26
FI763308A (no) 1977-05-22
GR62072B (en) 1979-02-20
DK157401C (da) 1990-05-21
CH633800A5 (en) 1982-12-31
IE44433L (en) 1977-05-21
BG34037A3 (en) 1983-06-15
DD127742A5 (de) 1977-10-12
KE3286A (en) 1983-06-17

Similar Documents

Publication Publication Date Title
NO147450C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolonderivater
NO149962C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazolderivater
NO143576C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser
SE434394B (sv) Analogiforfarande for framstellning av kinolonalkansyraderivat
SE431646B (sv) Forfarande for framstellning av acylaminosubstituerade femledade heterocykliska kveveforeningar
NO148848C (no) Analogifremgangsmaate ved fremstilling av nye antibiotisk aktive spiroimidazolidin-rifamyciner
NO146095C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive kinazolin-derivater
SE431544B (sv) Analogiforfarande for framstellning av farmakologiskt aktiva 4-pyrimidon-derivat
NO147109C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive diazepin-derivater
NO151040C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-halogenpyrimid-2-oner
NO145791C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive imidazolderivater
NO146096C (no) Analogifremgangsmaate ved fremstilling av thienothiazinderivater
NO146359C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive cyproheptadinderivater
DK523676A (da) Fremgangsmade til fremstilling af n-alkylerede derivater af thienamycin
NO146022C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme benzofenonderivater
NO146571C (no) Analogifremgangsmaate ved fremstilling av anti-inflammatorisk aktive imidazoler
NO142260C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive tienotriazolodiazepinderivater
NO153298C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-methylenderivater av thienamycin
NO147485C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 8-aminomethylisoflavonderivater
NO143903C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-fluorpyrimidin-4-on-derivater
NO145197C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive morfolinforbindelser
NO149960C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive bis(nitrosoureido)-polyolderivater
NO144741C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiopyrano-pyrazoler
SE421793B (sv) Analogiforfarande for framstellning naftyridinsubstituerade pyrrolderivat
NO141608C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive alkanolaminderivater